Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results Academic Article 2007 uri icon

authors

  • Gatell J
  • Van den Dungen M
  • Gruber C
  • Ledesma E
  • SWAN Study Group
  • GUTIERREZ RODERO, FELIX
  • Salmon-Ceron D
  • Lazzarin A
  • Van Wijngaerden E
  • Antunes F
  • Leen C
  • Horban A
  • Wirtz V
  • Odeshoo L

publication date

  • 2007